Investec Bank Plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc (AMS.L) under Rule 8.5 of the Takeover Code.
The disclosure was submitted on 8th September 2026, covering dealing activity that took place on 7th September 2026 in Advanced Medical Solutions Group ordinary shares.
Investec Bank Plc is acting as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the relevant offer period.
As an exempt principal trader with recognised intermediary status, Investec is required to publicly disclose its dealings under the Takeover Code when acting in a client-serving capacity.
During the disclosed dealing period, Investec purchased a total of 31,100 ordinary shares in Advanced Medical Solutions Group at a price of 281.25 pence per unit.
On the same date, the bank recorded sales of 36,640 ordinary shares, also transacted at a uniform price of 281.25 pence per unit.
Both the highest and lowest prices paid and received across purchases and sales were identical, at 281.25 pence per ordinary share.
No cash-settled derivative transactions, stock-settled derivatives, or options were reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that could serve as an inducement to deal or refrain from dealing in the relevant securities.
The firm also confirmed no agreements exist relating to voting rights under any option or future acquisition and disposal of securities to which any derivative is referenced.
The disclosure contact listed for this filing is Abhishek Gawde, reachable at the telephone number provided within the regulatory submission.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service for transparency in offer-period trading activity.
